AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

BACKGROUND: In Japan, nafamostat mesylate (NM) is frequently used as an anticoagulant during continuous renal replacement therapy (CRRT). The dialyzer membrane AN69ST has been reported to adsorb NM and affect the management of anticoagulant therapy. However, the adsorbed amount has not yet been quan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Intensive Care
Main Authors: Hirayama, Takahiro, Nosaka, Nobuyuki, Okawa, Yasumasa, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki, Ugawa, Toyomu, Nakao, Atsunori
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516335/
https://ncbi.nlm.nih.gov/pubmed/28729905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-017-0244-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados